Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System

The purpose of the current study is to look into the pathogenesis of a severe medical condition causing acute episodes on the central nervous system as seen in majority of patients with liver cirrhosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cirrhosis Brain Diseases Brain Diseases, Metabolic Central Nervous System Diseases Digestive System Diseases Fibrosis Hepatic Encephalopathy Hepatic Insufficiency Liver Diseases Liver Failure Metabolic Diseases Nervous System Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

45 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

PET Centre, Aarhus University Hospital

Aarhus, 8000, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

6 patients with liver cirrhosis with an acute episode of hepatic encephalopathy,
6 patients with liver cirrhosis without an acute episode of hepatic encephalopathy,
6 healthy subjects age and sex matched

Exclusion criteria

Neurological and/or psychiatric condition,
Non-treated diabetes,
Pregnancy/breast-feeding

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Registry information

Official study title

Brain Energy Metabolism in Patients With Acute Hepatic Encephalopathy Measured With PET

Important dates

Study start: 2006
Primary completion: 2007
Study completion: 2008
First posted: Jan 22, 2007
Registry last updated: Feb 5, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed